Lucas Bonacossa Sant’anna

Lucas Bonacossa Sant’anna

Auto-generated profile, based on publicly available information

Lucas Bonacossa Sant’anna

Fundação Técnico-Educacional Souza Marques (FTESM), Rio de Janeiro, RJ - Brasil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
SCSergio Menezes Couceiro
Sergio Menezes Couceiro
LSLucas Bonacossa Sant’aNna
Lucas Bonacossa Sant’aNna
MSMariana Bonacossa Sant’aNna
Mariana Bonacossa Sant’aNna
RMRenata S. Matos Menezes
Renata S. Matos Menezes
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
FSFernando Mendes Sant’aNna
Fernando Mendes Sant’aNna
Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min, [...] Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min,

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
FSFernando Mendes Sant’aNna
Fernando Mendes Sant’aNna
RRRodrigo César Lima Resende
Rodrigo César Lima Resende
LSLucas Bonacossa Sant’aNna
Lucas Bonacossa Sant’aNna
SCSérgio Lívio Menezes Couceiro
Sérgio Lívio Menezes Couceiro
RPRomero Bonacossa Soares Pinto
Romero Bonacossa Soares Pinto
EKEugenijus Kaniusas
Eugenijus Kaniusas
COVID-19 is an infectious disease caused by the new coronavirus (SARS-CoV-2), which invades alveolar epithelial cells through angiotensin-2 converting enzyme (ACE2) receptors1 1 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https://doi.org/10.1016/j.cell.2020.02.052 https://doi.org/10.1016/j.cell.2020.02.0... ,2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... . Infection is triggered by the binding of the spike protein (S) of SARS-CoV-1 or SARS-CoV-2 to ACE23 3 Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol. 2020;114(5):805-16. https://doi.org/10.36660/abc.20200279 https://doi.org/10.36660/abc.20200279... and, through this binding, the virus enters the host cell, where ACE2 is later inactivated. As this enzyme is abundantly found in alveolar epithelial cells and in the myocardium, potentially serious damage can occur in the lungs and heart2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... ,4 4 Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277 https://doi.org/10.1016/j.scitotenv.2020... .

31 March 2020 in Journal of Transcatheter Interventions
Verified
Journal Article
Open access
PDF file
LSLucas Bonacossa Sant’anna
Lucas Bonacossa Sant’anna
FSFernando Mendes Sant’anna
Fernando Mendes Sant’anna
SCSérgio Lívio Menezes Couceiro
Sérgio Lívio Menezes Couceiro
MPMaurício de Andrade Pérez
Maurício de Andrade Pérez
Objective: To assess the percentage of patients with normal coronary angiography in a hospital and to determine the predictor variables of this finding. Methods: All elective coronary angiographies performed from April to October 2018 were analyzed, excluding patients with valve diseases and who had a previous catheterization. A total of 503 patients were recruited, divided into 2 groups: Group A for normal coronary arteries, and group B for coronary artery disease. Coronary vessels with diameter ≥2.0mm and with no stenosis ≥40% determined by quantitative coronary angiography were considered normal. After the univariate analysis of the differences between groups, a multivariate analysis was performed by logistic regression, to determine the independent predictors of a normal exam. Results: The clinical characteristics were as follows: mean age of 62 years; 55% male; hypertension present in 86%; diabetes mellitus in 35%; smoking habit reported by 20.5%; dyslipidemia present in 20.5%; and family history of coronary artery disease in 59%. The prevalence of normal coronary angiography was 45%. In the univariate analysis, there were differences between the two groups in regard to sex, age, symptoms, diabetes mellitus and smoking habit. In the multivariate analysis, female sex (OR=3.22; 95%CI 2.20-4.80; p<0.0001), younger age (OR=0.96; 95%CI 0.94-0.98; p<0.0001), absence of diabetes mellitus (OR=0.46; 95%CI 0.30-0.70; p<0.0001), and no smoking habit (OR=0.33; 95%CI 0.19-0.55; p<0.0001) were predictors of normal coronary angiography. Conclusion: The prevalence of normal coronary arteries in this study was high. Female sex, younger age, absence of diabetes mellitus, and no smoking habit were independent predictors of this finding.

29 June 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
FSFernando Mendes Sant’aNna
Fernando Mendes Sant’aNna
LSLucas Bonacossa Sant’aNna
Lucas Bonacossa Sant’aNna
SCSérgio Lívio Menezes Couceiro
Sérgio Lívio Menezes Couceiro
A avaliação fisiológica intracoronária é estabelecida como uma estratégia valiosa para identificar estenoses epicárdicas limitantes de fluxo em pacientes com doença arterial coronariana (DAC) e para determinar uma indicação para intervenções coronárias percutâneas (ICP). Supunha-se anteriormente que, uma vez que a doença limitante do fluxo fosse confirmada por uma medida com fio-guia de pressão, a ICP guiada por angiografia deveria levar à restauração efetiva da condutância do vaso. No entanto, estudos com avaliação fisiológica pós-ICP com base na reserva de

1 January 2018 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
FSFernando Mendes Sant'Anna
Fernando Mendes Sant'Anna
LSLucas Bonacossa Sant'Anna
Lucas Bonacossa Sant'Anna

27 January 2022 in Journal of Transcatheter Interventions
Verified
Journal Article
Open access
PDF file
FSFernando Mendes Sant’anna
Fernando Mendes Sant’anna
DBDaniel Gustavo Sabino Ferreira Bandeira
Daniel Gustavo Sabino Ferreira Bandeira
LSLucas Bonacossa Sant’anna
Lucas Bonacossa Sant’anna
BCBruno Casagrande
Bruno Casagrande
JMJúlio de Paiva Maia
Júlio de Paiva Maia
DCDaniel Chamié
Daniel Chamié
Invasive physiological assessment of the coronary circulation has emerged in recent years as a valuable diagnostic approach in the management of patients with chronic coronary syndrome, overcoming important limitations such as evaluating function from the anatomy and the low spatial resolution associated with angiography or non-invasive tests. The value of hyperemic flow measurements to estimate the functional relevance of coronary stenoses is supported by many studies. The aim of this paper is to review the physiological bases, clinical applications and limitations of myocardial fractional flow reserve, the main index used in the invasive functional assessment of the coronary circulation.